Patents for A61P 35 - Antineoplastic agents (221,099)
11/2008
11/27/2008US20080293647 Combined Use Of Vitamin D Derivatives And Anti-Proliferative Agents For Treating Bladder Cancer
11/27/2008US20080293618 Cyclopropyl-fused pyrrolidine derivatives as dipeptidyl peptidase iv inhibitors
11/27/2008US20080293163 Methods to identify compounds that modulate rage
11/27/2008US20080293137 Compounds that abrogate dna damage induced cell cycle g2 checkpoint and/or augment anti-cancer activity of dna-damaging treatments
11/27/2008US20080293116 Ovary-specific genes and proteins
11/27/2008US20080293103 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
11/27/2008US20080292733 Antioxidant and Fe2+ Chelating Properties of Herbal Extracts
11/27/2008US20080292729 Stabilized Chlorite Solutions in Combination with Fluoropyrimidines for Cancer Treatment
11/27/2008US20080292707 Pharmaceutical Compositions of Adsorbates of Amorphous Drug
11/27/2008US20080292703 Antitumoral Bioconjugates of Hyaluronic Acid or Its Derivatives Obtained by Indirect Chemical Conjugation, and Their Use in the Pharmaceutical Field
11/27/2008US20080292687 Methods of Treating Cancer and Other Conditions or Disease States Using Lfmau and Ldt
11/27/2008US20080292647 immunogenic protein in a biodrug, was encoded from an isolated host cell transfected with the recombinant expression vector; anticarcinogenic agent for treating skin cancer; vaccine for prevention and treatment; immunotherapy
11/27/2008US20080292637 Therapeutic Uses of A3 Adenosine Receptor Antibodies
11/27/2008US20080292631 Treatment with anti-vegf antibodies
11/27/2008US20080292626 Kinesin inhibitors
11/27/2008US20080292624 Method of detecting and treating tuberous sclerosis complex associated disorders
11/27/2008US20080292616 Topical Formulations of Histone Deacetylase Inhibitors and Methods Using the Same
11/27/2008US20080292614 DNA sequences for human angiogenesis genes
11/27/2008US20080292609 Use of Arginase in Combination with 5FU and Other Compounds for Treatment of Human Malignancies
11/27/2008US20080292591 localized foci of model tumor cells highly correlated to actual clinical tumor cells; genetic engineering; drug screening
11/27/2008US20080292585 Azonafide Derivatives, Methods for Their Production and Pharmaceutical Compositions Therefrom
11/27/2008US20080292583 Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroindol-2-yl)-piperidine-2,6-dione following autologous stem cell transplantation
11/27/2008US20080292582 imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents; sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents; drug abuse/withdrawl; 1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea
11/27/2008US20080292553 Phosphoramidate Derivatives of Fau
11/27/2008US20080292544 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/27/2008DE202008012041U1 Vaginalzäpfchen auf Basis von 3,3'-Dindolylmethan (Methindol) Vaginal suppositories based on 3,3'-Dindolylmethan (Methindol)
11/27/2008DE102007024470A1 New sulfoximine-substituted quinoline and/or quinazoline derivatives are erythropoietin-producing hepatoma amplified sequence-receptor kinase inhibitors useful to prepare medicaments to e.g. treat endometriosis and stenosis
11/27/2008DE102007023614A1 New amide compounds used for treatment of gynecological diseases e.g. endometriosis, for female fertility control and female hormone replacement therapy, has general formula
11/27/2008CA2691997A1 Triazolyl aminopyrimidine compounds
11/27/2008CA2688823A1 Heterocyclic kinase modulators
11/27/2008CA2687633A1 Amino acid sequences directed against growth factor receptors and polypeptides comprising the same for the treatment of diseases and disorders associated with growth factors and their receptors
11/27/2008CA2687611A1 Novel sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibitors
11/27/2008CA2687535A1 Phosphate-modified oligonucleotide analogs with enhanced immunostimulatory activity
11/27/2008CA2687523A1 Chimeric pufa polyketide synthase systems and uses thereof
11/27/2008CA2687474A1 Triazolyl aminopyrimidine compounds
11/27/2008CA2687283A1 Quinazolin-oxime derivatives as hsp90 inhibitors
11/27/2008CA2687247A1 Inhibition of tumor metastasis by anti neuropilin 2 antibodies
11/27/2008CA2687160A1 Spiroindolinone derivatives
11/27/2008CA2687117A1 Single-chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto
11/27/2008CA2686675A1 3,3-spiroindolinone derivatives
11/27/2008CA2686421A1 P38.alpha. as a therapeutic target in bladder carcinoma
11/27/2008CA2686016A1 Quinoline derivatives as pi3 kinase inhibitors
11/27/2008CA2685907A1 Method for diagnosis and treatment of pancreatic cancer
11/27/2008CA2685049A1 Antibodies useful for therapy and diagnosis of cancer
11/27/2008CA2683452A1 Use of an anti-cxcr4 antibody for treating cancer
11/27/2008CA2680661A1 Mutant reoviruses and methods of making and using
11/27/2008CA2654877A1 Stable elsamitrucin salts suitable for pharmaceutical formulations
11/26/2008EP1995256A1 EPHA2 T-cell epitope agonists and uses therefor
11/26/2008EP1995249A1 Camptothecin derivatives and their use
11/26/2008EP1995238A2 Novel tetrahydrocarbazole derivatives with improved biological action and improved solubility as ligands for g-protein coupled receptors (GPCRS)
11/26/2008EP1994940A1 Therapeutic use of a recombinant erythropoietin having high activity and reduced side effects
11/26/2008EP1994152A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/26/2008EP1994044A2 DERIVATIVES OF 18ß-GLYCYRRHETINIC ACID
11/26/2008EP1994033A1 Indolopyridines as eg5 kinesin modulators
11/26/2008EP1994030A1 Multi-cyclic compounds and method of use
11/26/2008EP1994028A1 Quinoline derivatives for treating cancer
11/26/2008EP1994023A1 Quinazoline derivatives
11/26/2008EP1994003A1 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them .
11/26/2008EP1994002A1 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them
11/26/2008EP1994000A2 Water-soluble cc-1065 analogs and their conjugates
11/26/2008EP1993999A1 Improved prodrugs of cc-1065 analogs
11/26/2008EP1993595A1 Tumour vaccine comprising allogeneic or xenogeneic tumour cells
11/26/2008EP1993558A2 Oxysterol compounds and the hedgehog pathway
11/26/2008EP1993553A1 Methods for cancer therapy and stem cell modulation
11/26/2008EP1993530A2 Use of dha and ara in the preparation of a composition for regulating gene expression
11/26/2008EP1515736B1 Compositions against inflammatory processes
11/26/2008EP1496914B1 (20S)-1alpha-HYDROXY-2alpha-METHYL AND 2beta-METHYL-19-NOR-VITAMIN D3 AND THEIR USES
11/26/2008EP1438296B1 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
11/26/2008EP1421070B1 New piperidinyl derivates as modulators of chemokine receptor activity
11/26/2008EP1414455B1 Isoquinoline inhibitors of p38
11/26/2008EP1365763B1 Farnesyl protein transferase inhibitor combinations with antiestrogen agents
11/26/2008EP1330452B1 Pyrazine derivatives as modulators of tyrosine kinases
11/26/2008EP1328267B1 Method of treating cancer using dithiocarbamate derivatives
11/26/2008EP1299110B1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and antimetabolites
11/26/2008EP0865293B1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling
11/26/2008CN101313219A A method of diagnosis and treatment and agents useful for same
11/26/2008CN101313063A Cancer-rejection antigen peptide derived from glypican-3 (GPC3) for use in HLA-A2-positive patient and pharmaceutical comprising the antigen
11/26/2008CN101313061A Method of expanding double negative t cells
11/26/2008CN101312989A Monoclonal antibodies against claudin-18 for treatment of cancer
11/26/2008CN101312986A Method of producing a modified (poly)peptide
11/26/2008CN101312970A 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof
11/26/2008CN101312960A F,G,H,I and K crystal forms of imatinib mesylate
11/26/2008CN101312958A 3, 6-dihydro-2-oxo-6H-(1,3,4)thiadiazine derivatives
11/26/2008CN101312956A Substituted 5-phenyl-3,6-dihydro-2-oxo-6H-[1,3,4]thiadiazines
11/26/2008CN101312954A 4-aminopyrimidine-5-thione-derivatives for the treatment of cancer
11/26/2008CN101312737A Parapoxviruses in combination with classical cytotoxic chemotherapeutic agents as biochemotherapy for the treatment of cancer
11/26/2008CN101312722A Modulators of atp-binding cassette transporters
11/26/2008CN101311270A Eucaryon expression vector capable of inducing cell immunological response and vaccine thereof
11/26/2008CN101311193A Complexes using recombined triple helix support as base
11/26/2008CN101311192A Process for high-efficiency expressing sTNFR/Fc fusion protein in yeast and uses thereof
11/26/2008CN101311188A Small molecule peptides inhibitor of human heparinase
11/26/2008CN101311187A Tripterine derivate, preparation method and use thereof
11/26/2008CN101311174A Vitamin B6 derivates and pharmaceutical use thereof
11/26/2008CN101311173A Herpe-lactone, preparation method and use thereof
11/26/2008CN101311166A Tyrosine kinase restraining agent, preparation method thereof and use
11/26/2008CN101310770A Antibodies against cancer
11/26/2008CN101310768A Medicine composition for treating hepatic disease and use thereof
11/26/2008CN101310767A Cryosurgery anticancer antigen preparation and preparation method thereof
11/26/2008CN101310753A Analgesic and anticancer plaster and preparation method thereof
11/26/2008CN101310742A Tibetan medicine Honglian extract and use thereof